SCIENTURE HOLDINGS, INC. Payments for (Proceeds from) Investments
SCIENTURE HOLDINGS, INC. (SCNX) reported Payments for (Proceeds from) Investments of $2.50 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. payments for (proceeds from) investments for the quarter ending 2024-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. payments for (proceeds from) investments for the quarter ending 2024-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. payments for (proceeds from) investments for the quarter ending 2024-06-30 was $0.00.
- SCIENTURE HOLDINGS, INC. payments for (proceeds from) investments for the quarter ending 2024-03-31 was $2.50M, a 2771.19% increase year-over-year.
- SCIENTURE HOLDINGS, INC. payments for (proceeds from) investments for fiscal 2024 was $2.50M.
- SCIENTURE HOLDINGS, INC. payments for (proceeds from) investments for fiscal 2018 was $250.27K.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 6 month | Payments for (Proceeds from) Investments 9 month | Payments for (Proceeds from) Investments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | $2.50M 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $2.50M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.50M 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $2.50M 10-Q · filed 2025-05-12 | |||
| 2023-03-31 | $87.07K 10-Q · filed 2024-06-26 | |||
| 2019-06-30 | -$268.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | -$58.85K 10-Q · filed 2019-07-26 | ||
| 2019-03-31 | $210.00K 10-Q · filed 2019-05-13 | |||
| 2018-12-31 | $250.27K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |